Important Mixing Guidelines Inject the bacteriostatic water slowly down the side of the vial Do not spray the water directly onto the peptide powder Allow the peptide to dissolve naturally Swirl gently if needed do not shake the vial Shaking may damage the delicate peptide structure Once fully mixed, the solution should appear clear and free of visible particles Use sterile handling practices and avoid repeated contamination of the vial Storage Guidelines Store the unmixed lyophilized vial in a cool, dark place After reconstitution, refrigerate at 28C Avoid direct sunlight and repeated heat exposure Keep the vial sealed and sterile between uses Research Administration Guide Typical Research Protocol Begin with the lowest effective research amount Many research protocols begin at 0.25mg once weekly for approximately 4 weeks Administration amounts are commonly adjusted approximately every 4 weeks depending on response and tolerability Some research protocols maintain lower administration amounts for extended periods if desired research outcomes remain consistent Gradual administration escalation is commonly utilized to support tolerability and minimize gastrointestinal side effects Typically researched as a once-weekly peptide Important Notice This product is supplied strictly for laboratory and research purposes only
For unopened Ozempic, the medication should ideally be refrigerated until first use
Ozempic is technically only FDA-approved for treatment in type 2 diabetics, and Wegovy is only FDA-approved for patients with a body mass index (the measure of body fat based on your height and weight) above 30, or 27 if you have weight-related comorbidities like hypertension (high blood pressure) or hyperlipidemia (high levels of fat concentration in the blood), says Dr
Specifications Application References Li R, Ye Z, She D, Fang P, Zong G, Hu K, Kong D, Xu W, Li L, Zhou Y, Zhang K, Xue Y (2022)
Over time, this medication may help promote weight loss, especially when paired with a low-fat diet
